A Study of LY3002815 in Healthy Participants

Summary

The purposes of this study are to determine: * The safety of the study drug and any side effects that might be associated with it. * How much of the study drug gets into the blood stream and how long it takes the body to remove it in healthy participants. Participants will be admitted to the Clinical Research Unit (CRU) for 3 overnight stays. This study involves a single dose of LY3002815 or placebo given as an injection into the vein. This study will last approximately 16 weeks including screening. Additional follow-up may be required. This study is for research purposes only, and is not intended to treat any medical condition.

Timeline

Start

2017-05-24

Primary completion

2017-12-15

Completion

2018-09-26

Outcome

Outcome not reported

Stopped (Business): “due to business decisions”

Drugs

Indications

No indication recorded.